A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer
Copyright © 2022 Elsevier B.V. All rights reserved..
Oral or mouth cancer is the 16th most common form of cancer among the world's topmost malignancies. Healthy lifestyle and control of known risk factors can reduce its incidences further. Patients succumb to oral cancer when diagnosed late and lack timely access to tertiary care. Molecular biomarkers might help in early detection of oral cancer. Recently, researchers have identified numerous microRNAs which play a crucial role in promoting and suppressing oral cancers. miRNAs are short non-coding RNA molecules (18-22 nucleotides) that play a pivotal role in regulating gene expression. Understanding the miRNA interplays in oral cancers could augment the development of potential diagnostic, prognostic, and therapeutic tools. Liquid biopsy- a non-invasive approach that has been used lately, allows the determination of miRNAs in biological fluids that play essential roles in tumor suppression and cancer promotion. Herein, we summarize an update on the role of miRNAs in the diagnosis and treatment of oral cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:180 |
|---|---|
| Enthalten in: |
Critical reviews in oncology/hematology - 180(2022) vom: 25. Dez., Seite 103850 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dar, Ghulam Mehdi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers, Tumor |
|---|
| Anmerkungen: |
Date Completed 29.11.2022 Date Revised 29.11.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.critrevonc.2022.103850 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347758177 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347758177 | ||
| 003 | DE-627 | ||
| 005 | 20231226034611.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.critrevonc.2022.103850 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM347758177 | ||
| 035 | |a (NLM)36261117 | ||
| 035 | |a (PII)S1040-8428(22)00274-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dar, Ghulam Mehdi |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2022 | ||
| 500 | |a Date Revised 29.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
| 520 | |a Oral or mouth cancer is the 16th most common form of cancer among the world's topmost malignancies. Healthy lifestyle and control of known risk factors can reduce its incidences further. Patients succumb to oral cancer when diagnosed late and lack timely access to tertiary care. Molecular biomarkers might help in early detection of oral cancer. Recently, researchers have identified numerous microRNAs which play a crucial role in promoting and suppressing oral cancers. miRNAs are short non-coding RNA molecules (18-22 nucleotides) that play a pivotal role in regulating gene expression. Understanding the miRNA interplays in oral cancers could augment the development of potential diagnostic, prognostic, and therapeutic tools. Liquid biopsy- a non-invasive approach that has been used lately, allows the determination of miRNAs in biological fluids that play essential roles in tumor suppression and cancer promotion. Herein, we summarize an update on the role of miRNAs in the diagnosis and treatment of oral cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Head & Neck Cancers | |
| 650 | 4 | |a Liquid Biopsy | |
| 650 | 4 | |a MiR-therapies | |
| 650 | 4 | |a MiRNA | |
| 650 | 4 | |a Oncomirs | |
| 650 | 4 | |a Oral Cancer | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Agarwal, Shreya |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Nimisha |e verfasserin |4 aut | |
| 700 | 1 | |a Apurva |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Abhay Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Verma, Renu |e verfasserin |4 aut | |
| 700 | 1 | |a Sattar, Real Sumayya Abdul |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Ejaj |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, Asgar |e verfasserin |4 aut | |
| 700 | 1 | |a Mahajan, Bhawna |e verfasserin |4 aut | |
| 700 | 1 | |a Saluja, Sundeep Singh |e verfasserin |4 aut | |
| 700 | 1 | |a Meher, Ravi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical reviews in oncology/hematology |d 1996 |g 180(2022) vom: 25. Dez., Seite 103850 |w (DE-627)NLM012606006 |x 1879-0461 |7 nnns |
| 773 | 1 | 8 | |g volume:180 |g year:2022 |g day:25 |g month:12 |g pages:103850 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.critrevonc.2022.103850 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 180 |j 2022 |b 25 |c 12 |h 103850 | ||